Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and ixabepilone

thiazoles has been researched along with ixabepilone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borzilleri, R; Fairchild, CR; Kim, SH; Kramer, RA; Lee, FY; Long, BH; Reventos-Suarez, C; Rose, WC; Vite, GD1
Cheson, BD; Colevas, AD; West, PJ1
Bhalla, KN; Huang, Z; Lee, MW; Paranawithana, SR; Wang, HG; Yamaguchi, H1
Bali, P; Bhalla, K; Fumero, C; Griffin, D; Guo, F; Nimmanapalli, R; O'Bryan, E; Paranawithana, S; Wang, HG; Wittman, S1
Corey, SJ; Park, BJ; Whichard, ZL1
Herbolsheimer, P; Jelinek, J; Kapoor, R; Perry, D; Smith, KL; Swain, SM; Verma, N; Veytsman, I1
Gleave, ME; Loriot, Y; Zoubeidi, A1
Chang, AY; Wang, M1

Reviews

1 review(s) available for thiazoles and ixabepilone

ArticleYear
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptor.
    The Urologic clinics of North America, 2012, Volume: 39, Issue:4

    Topics: Bone Neoplasms; Cell Proliferation; Cell Survival; Dasatinib; Disease Progression; DNA Repair; Epothilones; Gene Fusion; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Pyrimidines; Receptors, Androgen; Taxoids; Thiazoles

2012

Trials

1 trial(s) available for thiazoles and ixabepilone

ArticleYear
Phase I trial of dasatinib and ixabepilone in patients with solid tumors.
    Investigational new drugs, 2013, Volume: 31, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Epothilones; Female; Humans; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Tubulin Modulators

2013

Other Studies

6 other study(ies) available for thiazoles and ixabepilone

ArticleYear
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:5

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Epothilones; Epoxy Compounds; Female; Humans; Infusions, Parenteral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Sarcoma; Thiazoles; Tubulin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2001
Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).
    Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:9

    Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation; Epothilones; Epoxy Compounds; Female; Humans; Male; Mice; Neoplasms; Thiazoles

2001
Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells.
    Cancer research, 2002, Jan-15, Volume: 62, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Epothilones; Epoxy Compounds; G2 Phase; Humans; Mitochondria; Mitosis; Protein Conformation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Thiazoles; Tumor Cells, Cultured

2002
Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
    Blood, 2002, May-01, Volume: 99, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Drug Synergism; Epothilones; Epoxy Compounds; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Macrolides; Membrane Glycoproteins; Mitochondrial Proteins; Peptide Fragments; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha

2002
Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
    Cancer letters, 2012, Jul-01, Volume: 320, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Breast Neoplasms; Butadienes; Cell Line, Tumor; Chromones; Dasatinib; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epothilones; Female; Humans; Morpholines; Niacinamide; Nitriles; Paclitaxel; Phenylurea Compounds; Pyridines; Pyrimidines; Signal Transduction; Sirolimus; Sorafenib; Tamoxifen; Thiazoles

2012
In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.
    Anti-cancer drugs, 2013, Volume: 24, Issue:3

    Topics: Alanine; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Hepatocellular; Cetuximab; Dasatinib; Doxorubicin; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperidines; Pyridones; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; Triazines

2013